A Promising Approach In The Prevention And Treatment Of Pancreatic Cancer
Sep 30th 2008Drug InformationGastroIntestinal / Gastroentorology
Many gastrointestinal tumors, including pancreatic cancer, have been shown to overexpress the EGFR. The overexpression of EGFR correlates with rapidly progressive disease and poor prognosis. Targeting EGFR pathway as a potential therapeutic strategy for pancreatic cancer has been developed. Erlotinib is a small molecule tyrosine kinase inhibitor that efficiently blocks EGFR.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
